Suppr超能文献

新冠长期症状概述:应对后遗症

Overview of Long COVID: Navigating the Aftermath.

作者信息

Duenas Katelyn, Chwa Won Jong, Hoque Farzana

机构信息

Saint Louis University.

Division of Hospital Medicine Saint Louis University.

出版信息

J Brown Hosp Med. 2025 Apr 1;4(2):133879. doi: 10.56305/001c.133879. eCollection 2025.

Abstract

The coronavirus disease (COVID-19) pandemic was a global health crisis with far-reaching consequences. Among these were physical and mental health complications that emerged weeks or even months after the initial COVID-19 infection, collectively termed "long COVID" or "post-COVID syndrome." Identifying the epidemiology, risk factors, clinical manifestations, and management strategies for long COVID is crucial for both clinicians and patients, which is the focus of this review. The prevalence of long COVID varies across studies, generally ranging from 5% to 20%. Prominent risk factors include female sex, older age, a high number of acute symptoms, lower socioeconomic status, and underlying comorbidities such as diabetes, asthma, or chronic obstructive pulmonary disease. The clinical manifestations of long COVID are diverse; beyond the commonly reported symptoms of fatigue, malaise, ageusia, and anosmia, neuropsychiatric complications such as headache, cognitive deficits, and depression are also potential outcomes. Although there is currently no consensus on the management of long COVID, multidisciplinary care teams with appropriate referrals and follow-up diagnostic studies are essential in evaluating the clinical course of long COVID patients.

摘要

冠状病毒病(COVID-19)大流行是一场具有深远影响的全球健康危机。其中包括在初次感染COVID-19数周甚至数月后出现的身心健康并发症,统称为“长期COVID”或“COVID后综合征”。确定长期COVID的流行病学、危险因素、临床表现和管理策略对临床医生和患者都至关重要,这是本综述的重点。不同研究中,长期COVID的患病率有所不同,一般在5%至20%之间。突出的危险因素包括女性、年龄较大、急性症状较多、社会经济地位较低以及潜在的合并症,如糖尿病、哮喘或慢性阻塞性肺疾病。长期COVID的临床表现多种多样;除了常见的疲劳、不适、味觉减退和嗅觉减退症状外,神经精神并发症,如头痛、认知缺陷和抑郁也是可能的后果。尽管目前对于长期COVID的管理尚无共识,但多学科护理团队进行适当的转诊和后续诊断研究对于评估长期COVID患者的临床病程至关重要。

相似文献

1
Overview of Long COVID: Navigating the Aftermath.
J Brown Hosp Med. 2025 Apr 1;4(2):133879. doi: 10.56305/001c.133879. eCollection 2025.
2
[Expert consensus on the diagnosis and treatment of obstructive sleep apnea in women].
Zhonghua Jie He He Hu Xi Za Zhi. 2024 Jun 12;47(6):509-528. doi: 10.3760/cma.j.cn112147-20240206-00072.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis.
J Neurol Sci. 2022 Mar 15;434:120162. doi: 10.1016/j.jns.2022.120162. Epub 2022 Jan 29.
6
Assessment of health-related quality of life after mild COVID-19 infection.
Acta Psychol (Amst). 2024 Aug;248:104422. doi: 10.1016/j.actpsy.2024.104422. Epub 2024 Jul 25.
7
Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study.
Lancet Reg Health Eur. 2021 Jul;6:100122. doi: 10.1016/j.lanepe.2021.100122. Epub 2021 May 18.
9
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Cochrane Database Syst Rev. 2021 Feb 23;2(2):CD013665. doi: 10.1002/14651858.CD013665.pub2.
10
A Disease Hidden in Plain Sight: Pathways and Mechanisms of Neurological Complications of Post-acute Sequelae of COVID-19 (NC-PASC).
Mol Neurobiol. 2025 Feb;62(2):2530-2547. doi: 10.1007/s12035-024-04421-z. Epub 2024 Aug 12.

本文引用的文献

1
The knowns and unknowns of long COVID-19: from mechanisms to therapeutical approaches.
Front Immunol. 2024 Mar 4;15:1344086. doi: 10.3389/fimmu.2024.1344086. eCollection 2024.
2
Asthma is a risk factor for general fatigue of long COVID in Japanese nation-wide cohort study.
Allergol Int. 2024 Apr;73(2):206-213. doi: 10.1016/j.alit.2023.11.003. Epub 2023 Nov 22.
3
"The burden of post-acute COVID-19 symptoms in a multinational network cohort analysis".
Nat Commun. 2023 Nov 17;14(1):7449. doi: 10.1038/s41467-023-42726-0.
4
The WHO has declared the end of pandemic phase of COVID-19: Way to come back in the normal life.
Health Sci Rep. 2023 Sep 5;6(9):e1544. doi: 10.1002/hsr2.1544. eCollection 2023 Sep.
5
Long COVID and Significant Activity Limitation Among Adults, by Age - United States, June 1-13, 2022, to June 7-19, 2023.
MMWR Morb Mortal Wkly Rep. 2023 Aug 11;72(32):866-870. doi: 10.15585/mmwr.mm7232a3.
6
A Cross-Sectional Study of Symptom Prevalence, Frequency, Severity, and Impact of Long COVID in Scotland: Part I.
Am J Med. 2025 Jan;138(1):121-130. doi: 10.1016/j.amjmed.2023.07.004. Epub 2023 Jul 20.
7
The immunology of long COVID.
Nat Rev Immunol. 2023 Oct;23(10):618-634. doi: 10.1038/s41577-023-00904-7. Epub 2023 Jul 11.
8
Long- COVID and general health status in hospitalized COVID-19 survivors.
Sci Rep. 2023 May 19;13(1):8116. doi: 10.1038/s41598-023-35413-z.
9
Long COVID and rehabilitation.
J Formos Med Assoc. 2024 Jan;123 Suppl 1:S61-S69. doi: 10.1016/j.jfma.2023.03.022. Epub 2023 Apr 13.
10
Five cluster classifications of long COVID and their background factors: A cross-sectional study in Japan.
Clin Exp Med. 2023 Nov;23(7):3663-3670. doi: 10.1007/s10238-023-01057-6. Epub 2023 Apr 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验